One half of J&J’s treatment is Lazcluze, a pill that, like Astra’s Tagrisso, blocks a cancer-associated protein called EGFR.

AstraZeneca PLC AZN shares slid 1.34% to £114.52 Monday, on what proved to be an all-around rough trading session for the ...

AstraZeneca PLC AZN shares slid 1.19% to £113.16 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.30% to 8,663.80.

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

(Bloomberg) -- AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was ...

Shares of AstraZeneca PLC (LON:AZN – Get Free Report ... stock with a hold rating and five have given a buy rating to the company. The average 1 year target price among brokers that have ...

AstraZeneca Plc‘s win over shareholders who challenged its $3 billion sale of biotech firm Viela Bio Inc. was affirmed Wednesday by the Delaware Supreme Court.

The Cambridge, England-based pharmaceutical company said it will invest USD2.5 billion in China's capital to establish its sixth global strategic R&D centre alongside other major research and ...

AstraZeneca is making a $1bn investment for the long term, but what lies in store for investors over the next 12 months? Here ...

(Alliance News) - AstraZeneca PLC on Tuesday reported positive new study results for its lung cancer drug Tagrisso, strengthening its position as a "backbone" treatment for patients with EGFR-mutated ...

March 14, 2025--AstraZeneca and Erin Andrews have teamed up as part of a national public health campaign to educate and empower people to Get Body Checked Against Cancer. Erin is a passionate ...